The nucleus, a site for signal termination by sequestration and inactivation of p42/p44 MAP kinases

Journal of Cell Science

Volumn 114, Issue 19, 2001, Pages 3433-3443

  Volmat, V ^a   Camps, M ^a   Arkinstall, S ^a   Pouysseegur J ^a   Lenormand, P ^a  

^a CENTRE DE BIOCHIMIE   (France)

Author keywords

Cell nucleus; Growth factors; Protein kinases; Protein phosphatases; Signal transduction

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1ALPHA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE PHOSPHATASE 1; MITOGEN ACTIVATED PROTEIN KINASE PHOSPHATASE 2; PHOSPHOPROTEIN PHOSPHATASE; PROTEIN P42; PROTEIN P44; TYROSINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL NUCLEUS; CELL STIMULATION; CHINESE HAMSTER; CONTROLLED STUDY; CYTOPLASM; DEPHOSPHORYLATION; IMMUNOHISTOCHEMISTRY; MITOGENESIS; MONITORING; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; PROTEIN SYNTHESIS; SERUM; SIGNAL TRANSDUCTION;

AMINO ACID SEQUENCE; ANIMALS; BLOOD PROTEINS; CELL NUCLEUS; CELLS, CULTURED; CRICETINAE; CRICETULUS; CYTOPLASM; ENZYME ACTIVATION; FIBROBLASTS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; LUNG; MAP KINASE SIGNALING SYSTEM; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MITOGEN-ACTIVATED PROTEIN KINASES; MITOGENS; MOLECULAR SEQUENCE DATA; MUTAGENESIS; PHOSPHORYLATION; PROTEIN-TYROSINE-PHOSPHATASE; RIBOSOMAL PROTEIN S6 KINASES; TRANSCRIPTION FACTORS;

EID: 0034757776     PISSN: 00219533     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (56)

1. Two co-existing mechanisms for nuclear import of MAP kinase: Passive diffusion of a monomer and active transport of a dimer
2. Nuclear export of MAP kinase (ERK) involves a MAP kinase kinase (MEK)-dependent active transport mechanism
3. Inactivation of p42 MAP kinase by protein phosphatase 2A and a protein tyrosine phosphatase, but not CL100, in various cell lines
4. Requirement for integration of signals from two distinct phosphorylation pathways for activation of MAP kinase
5. Signaling in the yeast pheromone response pathway: Specific and high-affinity interaction of the mitogen-activated protein (MAP) kinases Kss1 and Fus3 with the upstream MAP kinase kinase Ste7
6. A conserved motif at the amino termini of MEKs might mediate high-affinity interaction with the cognate MAPKs
7. Notch inhibition of RAS signaling through MAP kinase phosphatase LIP-1 during C. elegans vulval development
8. Selective activation of the rat hepatic endosomal insulin receptor kinase. Role for the endosome in insulin signaling
9. Constitutive MAP kinase phosphatase (MKP-1) expression blocks G1 specific gene transcription and S-phase entry in fibroblasts
10. The dual specificity mitogen-activated protein kinase phosphatase-1 and -2 are induced by the p42/p44MAPK cascade
11. Reduced MAP kinase phosphatase-1 degradation after p42/p44MAPK-dependent phosphorylation
12. Nuclear translocation of p42/p44 mitogen-activated protein kinase is required for growth factor-induced gene expression and cell cycle entry
13. Dual specificity phosphatases: A gene family for control of MAP kinase function
14. Nuclear localization and regulation of erk- and rsk-encoded protein kinases
15. Disruption of the erp/mkp-1 gene does not affect mouse development: Normal MAP kinase activity in ERP/MKP-1-deficient fibroblasts
16. Regulation of nuclear transport in proliferating and quiescent cells
17. CRM1 is responsible for intracellular transport mediated by the nuclear export signal
18. A novel regulatory mechanism in the mitogen-activated protein (MAP) kinase cascade. Role of nuclear export signal of MAP kinase kinase
19. Interaction of MAP kinase with MAP kinase kinase: Its possible role in the control of nucleocytoplasmic transport of MAP kinase
20. A MAP kinase docking site is required for phosphorylation and activation of p90(rsk)/MAPKAP kinase-1
21. Use of vanadate as protein-phosphotyrosine phosphatase inhibitor
22. The mitogen activated protein kinase signal transduction pathway: From the cell surface to the nucleus
23. Coordinate, biphasic activation of p44 mitogen-activated protein kinase and S6 kinase by growth factors in hamster fibroblasts. Evidence for thrombin-induced signals different from phosphoinositide turnover and inhibition
24. Protein phosphatases and the regulation of mitogen-activated protein kinase signalling
25. Phosphorylation of the MAP kinase ERK2 promotes its homodimerization and nuclear translocation
26. Significance of nuclear relocalization of ERK1/2 in reactivation of c-fos transcription and DNA synthesis in senescent fibroblasts
27. Growth factor-induced p42/p44 MAPK nuclear translocation and retention requires both MAPK activation and neosynthesis of nuclear anchoring proteins
28. Oncogenic Raf-1 activates p70 S6 kinase via a mitogen-activated protein kinase-independent pathway
29. Growth factors induce nuclear translocation of MAP kinases (p42mapk and p44mapk) but not of their activator MAP kinase kinase (p45mapkk) in fibroblasts
30. Signal transduction through MAP kinase cascades
31. Two protein tyrosine phosphatases, Ptp2 and Ptp3, modulate the subcellular localization of the Hog1 MAP kinase in yeast
32. beta-arrestin 2: A receptor-regulated MAPK scaffold for the activation of JNK3
33. Biphasic and synergistic activation of p44mapk (ERK1) by growth factors: Correlation between late phase activation and mitogenicity
34. Molecular cloning and functional characterization of a novel mitogen-activated protein kinase phosphatase, MKP-4
35. Substrate recognition domains within extracellular signal-regulated kinase mediate binding and catalytic activation of mitogen-activated protein kinase phosphatase-3
36. Direct suppression of TCR-mediated activation of extracellular signal-regulated kinase by leukocyte protein tyrosine phosphatase, a tyrosine-specific phosphatase
37. Identification of the regulatory phosphorylation sites in pp42/mitogen-activated protein kinase (MAP kinase)
38. The MAP-kinase ERK2 is a specific substrate of the protein tyrosine phosphatase HePTP
39. Peroxovanadium compounds. A new class of potent phosphotyrosine phosphatase inhibitors which are insulin mimetics
40. Signal transduction. An arresting start for MAPK
41. PTP-SL and STEP protein tyrosine phosphatases regulate the activation of the extracellular signal-regulated kinases ERK1 and ERK2 by association through a kinase interaction motif
42. Nucleocytoplasmic traffic of MAP kinases
43. p42/p44 mitogen-activated protein kinases phosphorylate hypoxia-inducible factor 1alpha (HIF-1alpha) and enhance the transcriptional activity of HIF-1
44. Mitogen-activated protein kinase pathways
45. A constitutively active and nuclear form of the MAP kinase ERK2 is sufficient for neurite outgrowth and cell transformation
46. Conditional transformation of cells and rapid activation of the mitogen-activated protein kinase cascade by an estradiol-dependent human raf-1 protein kinase
47. Inhibition of T cell signaling by mitogen-activated protein kinase-targeted hematopoietic tyrosine phosphatase (HePTP)
48. Strong and persistent activation of inositol lipid breakdown induces early mitogenic events but not Go to S phase progression in hamster fibroblasts. Comparison of thrombin and carbachol action in cells acetylcholine receptors
49. Docking domains and substrate-specificity determination for MAP kinases
50. Identification of an extracellular signal-regulated kinase (ERK) docking site in ribosomal S6 kinase, a sequence critical for activation by ERK in vivo
51. Distinct, constitutively active MAPK phosphatases function in Xenopus oocytes: Implications for p42 MAPK regulation In vivo
52. A conserved docking motif in MAP kinases common to substrates, activators and regulators
53. Growth factor-stimulated protein synthesis is inhibited by sodium orthovanadate
54. Differential activation of p44mapk (ERK1) by alpha-thrombin and thrombin-receptor peptide agonist
55. Detection of ERK activation by a novel monoclonal antibody
56. Interaction of mitogen-activated protein kinases with the kinase interaction motif of the tyrosine phosphatase PTP-SL provides substrate specificity and retains ERK2 in the cytoplasm